Video

Vial to Ready-To-Administer Need and BD Solution Offerings in Acute Care

Vial to Ready-To-Administer Need and BD Solution Offerings in Acute Care

This webinar originally aired as part of CPhI Discover - 17-28 May 2021

Several factors motivate pharmaceutical companies and hospitals to use glass pre-fillable syringes (PFS) for Intravenous (IV) applications. By switching from vials and ampules to a glass PFS, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact ROI for hospital stakeholders.

Moreover, data suggests that approximately 92% of hospital stakeholders are willing to use prefilled syringes for multiple drugs.

For pharmaceutical companies, transitioning a fixed-dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules.

This session will examine the benefits and challenges associated with glass formats and will explore BD’s glass pre-fillable syringe with connection performance verified for IV applications.

Other Content from SAS BECTON DICKINSON FRANCE